Synergia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-06-2024
- Paid Up Capital ₹ 1.33 Cr
as on 15-06-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 15-06-2024
- Satisfied Charges ₹ 10.30 Cr
as on 15-06-2024
- Revenue 12.72%
(FY 2023)
- Profit 37.30%
(FY 2023)
- Ebitda 40.76%
(FY 2023)
- Net Worth 32.43%
(FY 2023)
- Total Assets 31.95%
(FY 2023)
About Synergia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.33 Cr.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹10.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Mittal, Krishnamohan Puvvada, and Sanjay Soor serve as directors at the Company.
- CIN/LLPIN
U15100MH2004PTC145390
- Company No.
145390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Synergia Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Mittal  | Nominee Director | 09-Dec-2021 | Current |
| Krishnamohan Puvvada | Nominee Director | 09-Dec-2021 | Current |
| Sanjay Soor | Nominee Director | 09-Dec-2021 | Current |
Financial Performance of Synergia Life Sciences.
Synergia Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.72% increase. The company also saw a substantial improvement in profitability, with a 37.3% increase in profit. The company's net worth Soared by an impressive increase of 32.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synergia Life Sciences?
In 2023, Synergia Life Sciences had a promoter holding of 40.00% and a public holding of 60.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uas Life Sciences India Private LimitedActive 10 years 10 monthsKrishnamohan Puvvada is a mutual person
Novozymes South Asia Private LimitedActive 26 years 5 monthsManish Mittal and Krishnamohan Puvvada are mutual person
Riata Life Sciences Private LimitedActive 12 years 20 daysManish Mittal, Krishnamohan Puvvada and 1 more are mutual person
Charges (Loans)
₹2.50 Cr
₹10.30 Cr
Charges Breakdown by Lending Institutions
- Others : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2019 | Others | ₹2.00 Cr | Open |
| 18 Oct 2019 | Others | ₹5.00 M | Open |
| 18 Sep 2006 | Bank Of Baroda | ₹4.30 Cr | Satisfied |
| 18 Sep 2006 | Bank Of Baroda | ₹4.00 Cr | Satisfied |
| 18 Sep 2006 | Others | ₹2.00 Cr | Satisfied |
How Many Employees Work at Synergia Life Sciences?
Synergia Life Sciences has a workforce of 119 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synergia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synergia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
